Arma Biosciences develops a simple, low-cost universal electrochemical sensor platform for comprehensive, real-time monitoring of various biomarkers, viruses, and nucleic acids. This technology enables decentralized diagnostics through at-home sample-to-read testing using non-invasive samples like capillary blood or saliva. The versatile sensing platform supports custom assay development for home-use, wearable, and implantable monitoring applications.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional health monitoring often relies on infrequent clinical visits and broad physiological measurements, lacking the granularity needed for personalized and timely intervention. Existing at-home testing solutions may not offer the same level of accuracy or molecular-level insights as lab-based diagnostics.
Solution
Arma Biosciences is developing a targeted biosensing platform designed for at-home use, enabling continuous monitoring of multiple physiological markers at the molecular level. This technology aims to provide individuals with real-time access to their personal health data, facilitating early detection of potential health issues and personalized intervention strategies. By offering molecular-level insights outside of a clinical setting, Arma Biosciences seeks to empower individuals to proactively manage their health and well-being. The platform intends to bridge the gap between traditional clinical testing and continuous, personalized health monitoring.
Target Audience
The primary target audience includes individuals seeking proactive and personalized health management, as well as healthcare providers looking for tools to enable remote patient monitoring and early disease detection.
Features
- At-home testing platform for convenient and frequent monitoring.
- Molecular-level analysis of physiological markers for detailed insights.
- Real-time data access for timely intervention.
- Personalized health monitoring tailored to individual needs.